Thomas Nusbickel
Keine laufenden Positionen mehr
Ursprung des Netzwerks ersten Grades von Thomas Nusbickel
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Medical/Nursing Services | 9 | |
| Public Company | Biotechnology | 6 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Thomas Nusbickel
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Sales & Marketing | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 1984 and is headquartered in Marlborough, MA. | Pharmaceuticals: Major | Sales & Marketing | |
UroCor, Inc.
 UroCor, Inc. Hospital/Nursing ManagementHealth Services UroCor, Inc. provides diagnostic and therapeutic services for urological disorders. It helps in detecting, diagnosing, treating & managing- prostate cancer, bladder cancer, kidney stones, and other complex urologic disorders. The company is located in Oklahoma City, OK | Hospital/Nursing Management | Corporate Officer/Principal Sales & Marketing | |
| KERYX BIOPHARMACEUTICALS | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| OMEROS CORPORATION | Pharmaceuticals: Major | Sales & Marketing | |
| GENOMIC HEALTH, INC. | Medical Specialties | Corporate Officer/Principal | |
| POXEL | Pharmaceuticals: Major | Chairman | |
| UCB | Pharmaceuticals: Major | Corporate Officer/Principal | |
The Community Hospital Group, Inc.
 The Community Hospital Group, Inc. Hospital/Nursing ManagementHealth Services The Community Hospital Group, Inc. operates hospitals. The medical center includes the Anthony M. Yelencsics Community Hospital, and the JFK Johnson Rehabilitation Institute, which offers physical therapy services. The company was established in 1967 and is headquartered in Edison, NJ. | Hospital/Nursing Management | Corporate Officer/Principal | |
| Bloomsburg University of Pennsylvania | College/University | Undergraduate Degree | |
| The University of Chicago | College/University | Masters Business Admin | |
| Miami University | College/University | Undergraduate Degree | |
| Sonoma State University | College/University | Undergraduate Degree | |
| University of Arizona | College/University | Doctorate Degree | |
| University of Michigan | College/University | Masters Business Admin | |
UCB Pharma SA
 UCB Pharma SA Chemicals: SpecialtyProcess Industries UCB Pharma SA manufactures pharmaceutical products. It develops products in areas, such as epilepsy, central nervous system, immunology and inflammation. The company is headquartered in Molins de Rei, Spain | Chemicals: Specialty | Corporate Officer/Principal | |
JDRF International
 JDRF International Miscellaneous Commercial ServicesCommercial Services JDRF International is a leader in setting the agenda for diabetes research worldwide, and is the largest charitable funder of and advocate for type 1 diabetes research. JDRF find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its potential complications, which may include kidney failure, blindness, heart disease, stroke, and amputation. It was founded in 1970 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Vedim Pharma SA
 Vedim Pharma SA Pharmaceuticals: MajorHealth Technology Part of UCB SA, Vedim Pharma SA is a French pharmaceutical company that manufactures pharmaceuticals. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Exosome Diagnostics, Inc.
 Exosome Diagnostics, Inc. Medical/Nursing ServicesHealth Services Exosome Diagnostics, Inc. develops and commercializes biofluid-based diagnostics to deliver personalized precision healthcare that improves lives. Its novel exosome-based technology platform can yield comprehensive and dynamic molecular insights to transform how cancer and other serious diseases are detected, diagnosed, treated and monitored. The company was founded by Wayne D. Comper, Harvey J. Barnett and James R. McCullough and is headquartered in Waltham, MA. | Medical/Nursing Services | Chief Operating Officer | |
UCB, Inc.
 UCB, Inc. Financial ConglomeratesFinance Part of UCB SA, UCB, Inc. provides financial services. The company is based in Smyrna, GA. The CEO of the company is Duane Barnes. | Financial Conglomerates | Director/Board Member | |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| UCB Pharma AS | Chairman | ||
| City University London | College/University | Undergraduate Degree | |
Da Volterra SA
 Da Volterra SA BiotechnologyHealth Technology Da Volterra develops a portfolio of products in the antibacterial field, with a specific focus on antibiotic resistance. Its productDAV132, developed to prevent the disruption of the intestinal microbiota and prevent Clostridium difficile infections associated with antibiotic use. The company was founded by Antoine Andremont in 2000 and is headquartered in Paris, France. | Biotechnology | Chairman | |
| University of Michigan Medical School | College/University | Doctorate Degree | |
| Juvenile Diabetes Research Foundation of Arizona, Inc. | Director/Board Member | ||
| ALSAR LP | President | ||
UCB Pharma Ltd.
 UCB Pharma Ltd. Pharmaceuticals: MajorHealth Technology UCB Pharma Ltd. operates as a biopharmaceutical company. The firm focuses on developing medicines for severe diseases in Immunology and CNS. The company is headquartered in Slough, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| UCB Pharma AB | Chairman | ||
| UCB Pharma Sp zoo | Chief Executive Officer | ||
NewPace Ltd.
 NewPace Ltd. Medical SpecialtiesHealth Technology NewPace Ltd. develops a novel implantable subcutaneous string defibrillator. It is used for the prevention of cardiac arrest. The company was founded by Robert S. Fishel in 2012 and is headquartered in Caesarea, Israel. | Medical Specialties | Founder | |
| LONGEVERON INC. | Biotechnology | Director/Board Member | |
Amneal Intermediate, Inc.
 Amneal Intermediate, Inc. Pharmaceuticals: MajorHealth Technology Amneal Intermediate, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It operates through the Generic, Specialty and AvKARE Segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The AvKARE segment focuses on pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| PROCESSA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Florida Electrophysiology Associates | Founder | ||
Renaissance Properties, Inc.
 Renaissance Properties, Inc. Real Estate DevelopmentFinance Renaissance Properties, Inc. is a real estate brokerage company. The private company is based in Old Bridge, NJ. The CEO of the company is Robert McDaid. | Real Estate Development | Director/Board Member | |
| Catalyst Development Partners LLC | Director/Board Member | ||
| Charles E. Schmidt College of Medicine | College/University | Corporate Officer/Principal | |
Brava Diagnostics, Inc.
 Brava Diagnostics, Inc. Medical SpecialtiesHealth Technology Brava Diagnostics, Inc.develops acute care diagnostic products. It specializes in IVD, point-of-care, cardiovascular, sepsis, and acute care services. The company was founded by Byron Hewett, David Okrongly and Carrie Mulherin in August 2018 and is headquartered in Boulder, CO. | Medical Specialties | Founder | |
| UCB AE | Chairman | ||
RareGen LLC
 RareGen LLC Miscellaneous Commercial ServicesCommercial Services RareGen LLC provides strategy, investment, and commercialization for rare disease pharmaceutical products. The company is headquartered in Durham, NC. | Miscellaneous Commercial Services | Founder | |
| LIQUIDIA CORPORATION | Pharmaceuticals: Major | Corporate Officer/Principal | |
| CLARUS THERAPEUTICS HOLDINGS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Cranfield School of Management | College/University | Masters Business Admin |
Statistik
International
| Vereinigte Staaten | 38 |
| Frankreich | 4 |
| Vereinigtes Königreich | 4 |
| Belgien | 2 |
| Spanien | 2 |
Sektoral
| Health Technology | 24 |
| Consumer Services | 11 |
| Health Services | 5 |
| Commercial Services | 3 |
| Finance | 3 |
Operativ
| Corporate Officer/Principal | 35 |
| Director/Board Member | 27 |
| Sales & Marketing | 12 |
| President | 11 |
| Chief Executive Officer | 10 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Thomas Nusbickel
- Unternehmensverbindungen
